1. Home
  2. NDSN vs UTHR Comparison

NDSN vs UTHR Comparison

Compare NDSN & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NDSN
  • UTHR
  • Stock Information
  • Founded
  • NDSN 1935
  • UTHR 1996
  • Country
  • NDSN United States
  • UTHR United States
  • Employees
  • NDSN N/A
  • UTHR N/A
  • Industry
  • NDSN Industrial Machinery/Components
  • UTHR Biotechnology: Pharmaceutical Preparations
  • Sector
  • NDSN Industrials
  • UTHR Health Care
  • Exchange
  • NDSN Nasdaq
  • UTHR Nasdaq
  • Market Cap
  • NDSN 14.5B
  • UTHR 15.5B
  • IPO Year
  • NDSN N/A
  • UTHR 1999
  • Fundamental
  • Price
  • NDSN $261.27
  • UTHR $372.89
  • Analyst Decision
  • NDSN Strong Buy
  • UTHR Buy
  • Analyst Count
  • NDSN 5
  • UTHR 14
  • Target Price
  • NDSN $303.00
  • UTHR $370.86
  • AVG Volume (30 Days)
  • NDSN 211.8K
  • UTHR 371.9K
  • Earning Date
  • NDSN 12-11-2024
  • UTHR 10-30-2024
  • Dividend Yield
  • NDSN 1.19%
  • UTHR N/A
  • EPS Growth
  • NDSN N/A
  • UTHR 25.10
  • EPS
  • NDSN 8.21
  • UTHR 22.72
  • Revenue
  • NDSN $2,664,752,000.00
  • UTHR $2,756,200,000.00
  • Revenue This Year
  • NDSN $4.12
  • UTHR $26.32
  • Revenue Next Year
  • NDSN $9.32
  • UTHR $10.37
  • P/E Ratio
  • NDSN $31.82
  • UTHR $16.41
  • Revenue Growth
  • NDSN 2.77
  • UTHR 25.04
  • 52 Week Low
  • NDSN $222.18
  • UTHR $208.62
  • 52 Week High
  • NDSN $279.38
  • UTHR $417.82
  • Technical
  • Relative Strength Index (RSI)
  • NDSN 58.74
  • UTHR 50.17
  • Support Level
  • NDSN $248.28
  • UTHR $353.65
  • Resistance Level
  • NDSN $259.51
  • UTHR $417.82
  • Average True Range (ATR)
  • NDSN 4.61
  • UTHR 11.15
  • MACD
  • NDSN 0.13
  • UTHR -3.43
  • Stochastic Oscillator
  • NDSN 74.65
  • UTHR 29.98

About NDSN Nordson Corporation

Nordson manufactures equipment (including pumps, valves, dispensers, applicators, filters, and pelletizers) used for dispensing adhesives, coatings, sealants, and other materials. The firm serves a diverse range of end markets including packaging, medical, electronics, and industrial. Nordson's business is organized into three segments: industrial precision solutions, medical and fluid solutions, and advanced technology solutions. The company generated approximately $2.6 billion in revenue in its fiscal 2023.

About UTHR United Therapeutics Corporation

United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.

Share on Social Networks: